YS-HBV-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YS-HBV-002, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 [Phase 1]